Overview
This course will provide an overview of the use of pharmacogenomic data to inform clinical and therapeutic decision making for gene-drug pairs across a range of conditions.
- Credit(s): 3
- Course Format: Asynchronous
- Required: This is an elective course.
- (GMS 6224) Foundations in Precision Medicine: Medical Molecular Genetics
- (PHA 6134) Foundations in Precision Medicine: Genomic Technologies
- (PHA 6935) Foundations in Precision Medicine: Genetic Epidemiology
- (PHA 6120) Principles of Pharmacogenomics
Course Objectives
Upon completion of this course, the student will be able to:
- Describe the role of pharmacogenomics in the patient care process
- Identify drugs whose clinical outcomes are affected by genetic variability
- Interpret and apply evidence for clinical utility of genotype-informed drug therapy
- Demonstrate evidence-based clinical decision making that incorporates clinical and genetic factors for patient case scenarios across a spectrum of diseases
- Communicate rationale for drug therapy changes informed by genotype
- Assess the effectiveness of genotype-informed drug therapy on the basis of clinical and laboratory parameters
- Identify the key components and steps required for the successful implementation of pharmacogenomics in clinical practice.